ANDA 75968, held by Graviti Pharms. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 75968 (Tramadol Hydrochloride), held by Graviti Pharms, was first approved by FDA on Jun 25, 2002, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 25, 2002 | Original application | Approved |
| Tramadol Hydrochloride50MG · tablet;oral | Tramadol Hydrochloride | Rx |
| Tramadol Hydrochloride100MG · tablet;oral | Tramadol Hydrochloride | Rx |
| Tramadol Hydrochloride25MG · tablet;oral | Tramadol Hydrochloride | Rx |
| Jul 28, 2026 | Supplement 18Manufacturing | Approved | None posted |
| Jun 18, 2026 | Supplement 23REMS | Approved | None posted |
| Dec 23, 2025 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 15REMS | Approved | None posted |
| Aug 2, 2024 | Supplement 14Manufacturing | Approved | None posted |
| May 28, 2024 | Supplement 12Manufacturing | Approved | None posted |
| Feb 1, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 11REMS | Approved | None posted |
| May 11, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| May 11, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 30, 2002 | Supplement 1Labeling | Approved | None posted |
| Jun 25, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters